IKK2 Gene Essential for Liver Development

For this article, Jim Kling interviewed Inder M. Verma, professor of genetics at the Salk Institute for Biological Studies. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more than the average paper of the same type and age. Q.T. Li, D. Van Antwerp, F. Mercurio, K.F. Lee, I.M. Verma, "Severe liver degeneration in mice lacking the I kappa B kinase 2 gene," Science, 284:321-5, April 9, 1999. (Cited in 150 papers) Courtesy of Inder M. VermaInder M.

Written byJim Kling
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The team started with IKK2 because IKK1 hadn't been cloned yet (it has since been1). "The question was, 'What is the role of each one of those kinases and what other roles might they play?'... not that we anticipated them to be that different," recalls Verma. In fact, they turned out to be very different.

The team created IKK2 knockout mice. They found that between days 12-13 and 13-14 of the gestation period, the animals died of liver apoptosis, probably due to tumor necrosis factor aTNFa. Although the researchers could detect weak normal IKK1 activity, the results made it clear that IKK1 could not make up for the absence of IKK2. In subsequent studies, the team made IKK1 knockouts and found that the animals survived gestation, but their limbs never extended and the animals died soon after birth.2,3 Double knockouts died at day 9-12 of the gestation period, and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies